Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agentsVittorio Emanuele Muccio, Paola Omedè, Marina Ruggeri et al.|Cytometry Part B Clinical Cytometry|2015Cited by 54
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapiesS Caltagirone, Paola Omedè, Marina Ruggeri et al.|Haematologica|2014Cited by 22
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow‐upPaola Ghione, Simone Ferrero, Elisa Genuardi et al.|British Journal of Haematology|2017Cited by 1